Prosecution Insights
Last updated: August 17, 2026

Examiner: GHAND, JENNIFER LEIGH-STEWAR

Tech Center 3700 • Art Units: 3762 3766 3791 3792 3796

This examiner grants 60% of resolved cases

Performance Statistics

60.4%
Allow Rate
-9.6% vs TC avg
744
Total Applications
+27.7%
Interview Lift
1353
Avg Prosecution Days
Based on 682 resolved cases, 2023–2026

Rejection Statute Breakdown

5.2%
§101 Eligibility
17.1%
§102 Novelty
44.5%
§103 Obviousness
26.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19045628 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
19022006 METHOD AND APPARATUS FOR ECAP-BASED DYNAMIC STIMULATION PROGRAMMING Non-Final OA Boston Scientific Neuromodulation Corporation
18937888 Closed Loop DBS Using Evoked Potentials Non-Final OA Boston Scientific Neuromodulation Corporation
18598460 NEUROANATOMY-BASED COMPARATIVE SEARCH TO OPTIMIZE DEEP BRAIN STIMULATION Non-Final OA Boston Scientific Neuromodulation Corporation
19104843 EMBEDDED SEIZURE DETECTION DURING THERAPEUTIC BRAIN STIMULATION Non-Final OA Mayo Foundation for Medical Education and Research
18288503 Handheld Auscultation Systems, Devices, and Methods Non-Final OA Emory University
17430629 ELECTROCARDIOGRAM WAVEFORM ANALYSIS APPARATUS Non-Final OA NIHON KOHDEN CORPORATION
18983323 TISSUE CONDUCTION COMMUNICATION USING RAMPED DRIVE SIGNAL Non-Final OA Medtronic, Inc.
17816605 IMPLANTABLE MEDICAL DEVICE Non-Final OA Medtronic, Inc.
18200973 NON-CONTACT VITAL-SIGN MONITORING SYSTEM AND METHOD Final Rejection Wistron Corporation
16716304 MATCHING AND TRACKING TIME SEQUENCES OF HEART ACTIVATION Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month